76425539-Pedia-tickler.doc

BOD! TEMPERATURE *!'orml Norml *!2erile e4er ;i"h 2e4er ;perpre


=36.6>+ 3?.%>+ 35.? @ 3A.0>+ 3A.0>+ 3.5>+ %#.0>+ HR "$%&

$reterm 9erm 0-3 mo 3-6 mo 6-1# mo 1-3 rs 3-6 rs 6-1# rs 1#-1? rs

ABG

BP "%%H'&

1#0-1?0 1#0-160 100-150 0-1#0 A0-1#0 ?0-110 65-110 60-5 55-A5

p;C p+#C p#C

RR "($%&

55-?535-%5 65-A5%5-55 65-A5%5-55 ?0-050-65 A0-10055- 65 0-10555- ?0 5-11060-?5 100-1#060-?5 110-13565-A5

%0-?0 30-60 35-55 30-%5 #5-%0 #0-30 #0-#5 1%-## 1# 1#-1A

RB+ RB+

NB %.A%.A-?. ?.1 1

I /, /,t 3.A3.A-5. 5.5 5

/ B+ B+ $MNs Lmph ;"

-30 00 000 61G 31G 1%-#%

6-1? 50 500 61G 3#G 11-#0

;,t

%%-6%G

35-%

$lt $ltel elets e ts 1%01%0-30 300 0 #00#00-%# %#3 3 Ret #.6-6.5 0.5-3.1

##-#6m7EL F- #m7EL ?G

C0i d 3.A3.A-5. 5.

Ado e MC %.6%.6-6. 6.# # C %.#-5.% 5-10 00 000 6-10 00 000 60G 60G 30G 30G 11-16 MC 1%-1A C 1#-16 31-%6 MC %0-5% C 3?-%? 150150-%5 %50 0 150150-%5 %50 0 0-# 0-#

IDEAL BOD! 3EIGHT A'e &t Birth

B9 +9 $99

C,.(,+i, =1A.5 1A.5 @ #%. #5 @ #.

1-5 mi' 1-6 5-A mi' 5-A 1#-#0se, 1#-1%

1-6 5-A 1#-1%

4io'5,%+ 3k" (il) 3.35k" (+!) &"e (mo) F   #

3-1# mo 1-6  ?-1# 

Po.d+ ? &"e (mo) F 10 () &"e (mo) F 11 (+) &"e () < 5 F 1? &"e () < ? F 5

&"e () < # F A &"e () < ? @ 5  #

Gi6e Bi5t0 3ei'0t7 A'e U+i' Bi5t0 3ei'0t i G5,%+ = 6 mo &" e ( mo mo) < 60 0 F i ir th th we wei "h "h t ( "m "m) 6-1# 6-1# mo &"e &"e (mo (mo)) < 500 500 F irt irth h wei wei"h "htt ("m ("m)) Ex$e(ted Bod8 3ei'0t "EB3&7 9er m &" e i ' d s s @ 10 10 < # 0 F Bi Bi rt rt h / ei ei"ht $re$re-9e 9erm rm &"e &"e i' i' d ds s @ 1% 1% < 15 15 F Bir Birth th /ei /ei"h "htt

COUNT "&

BMI A+i, =1A.5 1A.5 @ ##.  #3.0 #3 @ #%. #5 @ #.  30

;+3C B.7.C # stC

NORMAL LABORATOR! VALUES

B$ ,!22 sho!ld ,o4er 2)* o2 2)* o2 rm -C *M&LL ,!22C 2lsel hi"h B$ -C L&R87 ,!22C 2lsel low B$

U'derwei"ht Norml 4erwei"ht t risk ese I ese II

?.35-?.%5 35-%5 A0-100

ANTHROPOMETRIC MEASUREMENTS

A'e o/ I/,t %-5 mo'ths 1 er # ers 3 ers 5 ers ? ers 10 ers

1-6 5-A 1#-1%

Ide, 3ei'0t # < Birth /ei"ht 3 < Birth /ei"ht % < Birth /ei"ht 5 < Birth /ei"ht 6 < Birth /ei"ht ? < Birth /ei"ht 10 < Birth / ei"ht

30 @ 3. %0 APGAR

LENGTH ) HEIGHT (50 cm) A'e &t Birth 1 #-1# mo

Ceti%ete5+ 50 ?5 &"e < 6 F ??

A'e I(0e+ #0 30 &"e < #.5 F 30

&t Birth 1 6

T5,+6e5+e-AP Di,%ete5 5,tio 1.0 1.#5 1.35

I(0e+ 9r's4erse H &$ &$ 9r's4erse  &$ 9r's4erse  &$

ONTANELS G,i i 1+t !e,5 i+ 9 2:(% F  ,m 3 ,m per mo F A ,m #.6? per mo F 5 ,m 1.6 ,m per mo F 3 ,m 1 ,m per mo

A'e 0-3 mo 3-6 mo 6- mo -1# mo

&pproprite sie t irthC irthC +loses tC Anterior Posterior

I(0e+ 35 ,m (13.A i') F # i' (1# i',hes  mo) F # i' (1% i',hes  mo) F 1 i',h F 1.5 i' (1# i',hes  er) F 1.5 i' (1# i',hes  er)

5-1# mo 1-# rs 3-5 rs 6-#0 rs

AGE Birth or 6 wks

TI =

F 5.0A,m (1.#?,m  mo) F 5.0A,m (0.635,m  mo) #.5% ,m F 3.A1,m (1.#?,m  mo) F 3.A1,m (1.#?,m  mo)

DPT

6 wks

DOSE 0.05mL (NB) 0.1mL (older) 0.5mL

OPV HEPA B

6 wks 6 wks

# drops 0.5mL

3 3

$ IM

MEASLES

 mos

0.5mL

1

*+

BCG-2

*,hool e'tr

0.1mL

1

ID

TetToxoid

+hilderi'" wome'

0.5mL

3

IM

# 1

ROUTE ID

3

IM

Sex., ,(ti6itie+ J *e
J J J J J J J

l!ids Respirtio' I'2e,tio' Crdi, Hemtolo"i, Metoli, O!tp!t  I'p!t ,,k"h NC 1-#

8rim,es

A

(-) Mo4eme't

*ome 2le
R

&se't

*low  Irre"!lr

Norml Mild  Moderte &sph
tr's4erse ,hest dimeter &$ dimeter

.(tio E8e O$ei'

Birth 1 er 6 ers

Ve5,

C 1.0 C 1. 1.#5 C 1. 1 .35

I/,t+)!o.' %- *po't'eo!s 3- 9o spee,h #- 9o pi' 1- No'e 5- &pproprite %- I',o'solle 3- Irritle #- Mo's 1- No'e 6- *po't'eo!s 5- Lo,lie pi' %- /ithdrw 3- le
Moto5

SITE RDeltoid

Upper !ter thi"h Mo!th &'terolterl thi"h !ter !pper rm LDeltoid Deltoid

Ode5 *po't'eo!s 9o spee,h 9o pi' No'e rie'ted +o'2!sed I'pproprite I',omprehe'sile No'e *po't'eo!s Lo,lie pi' /ithdrw le
ADVERSE REACTIONS ROM VACCINES VACCINES INTERVAL

BCG

DPT

% wks % wks

OPV HEPA B MEASLES

1. /hel  smll  s,ess  !l,ertio'  heli'" heli'"  s,r 2ormtio' i' 12 wks #. Deep s,ess 2ormtio' i'dole't !l,ertio' "l'd!lr "l'd!lr e'lr"eme't s!pp!rti4e lmphde'itis 1. e4er lo,l lo,l sore'ess #. +o'4!lsio's e',ephlitis  e',ephlopth e',ephlopth perm'e't ri' dm"e $rlti, $olio Lo,l sore'ess 1. e4er  mild mild rsh #. +o'4!lsio's e',ephlitis  e',ephlopth e',ephlopth **$7 deth

% wks

1 mo the' 6-1# mos

H@E@A@D@S@S@S@

@R@I@C@H@M@O@N@D@

(-) Respo'se

P

2 +ompletel pi'k  100 +o!"hs *'eees +ries &,ti4e mo4eme't 8ood stro'" ,r

THORACIC INDEX

Ceti%ete5+

S,/et8 J Use sete setelts ltshe helme lmetsK tsK J 7'ter 7'ter i'to i'to hi"h hi"h risk risk sit!ti sit!tio's o'sK K J Memer Memer o2 2rt 2rtsor sorori oritor"s t or"sK K J ire irer rm m t t hom homeK eK

G

A

< = 1;7 1;7 > = ?7 ; = *7

EXPANDED EXPANDED PROGRAM ON IMMUNIZATION VACCINE BCG-1

1 $i'k od Bl!e e
GCS

HEAD CIRCUMERENCE (33-38 cms) A'e &t Birth = % mo

# < # ,m ('terior) H 1A mo'ths or s erl s -1# mo'ths H 6 @ A weeks or # @ % mo'ths

; Bl!e  $le &se't

H@E@A@D@S@S@S@ Ho%e E6i5o%et J / it h whom do does th the d doles,e't lili4 eK eK J &' re,e't ,h'"es i' t he he li4 i'" sit!tio'K J ;ow r re th thi'"s m mo'" si sili'"sK J &re pre'ts emploedK J &r e t he her e t hi hi '" '"s i' t he he 2 m mi l l he s s he he w'ts to ,h'"eK E%$o8%et ,d Ed.(,tio J + !r !r re re 't 't l l t t s, s, ho hoo lK  4 or ori te te s! s! O O e, e, ts ts K J $tie't pe per2 or ormi'" , , d demi,llK J ;4 e ee' tr!'t  e
/ht heshe do does i' i' spre timeK $tie't does 2or 2!'K / ho hom does p ptie't sp spe'd sp spre titimeK ;oies i' i'terests ,l ,lose 2r 2rie'dsK

Used to,,o l l,ohol st steroidsK Illi, itit dr dr!"sK r reE!e', K K &m &mo!'t K &22e,ted dil ,ti4itiesK J *t ilil l !s i' i'"K  ririe 'd 'ds !s i' i'" se sel li '" '"K

ACTIVE B+8 D$9 $: ;ep B Mesles ;i MMR 9et'!s 9o
PASSIVE Diphtheri 9et'!s 9et'!s I" Mesles I" Ries (;RI") ;ep & I" ;ep B i" R!ell I"

NUTRITION AGE 0-5 mo A-11 mo 1-#  3-6  ?-  10-1#  13-15  16-1 

3T@ 3-6 ?- 10-1# 1%-1A ##-#% #A-3# 36-%% %A-55

TCR  TCR

CAL 115 110 110 0-100 A0-0 ?0-A0 55-65 %5-50

CHON 3.5 3.0 #.5 #.0 1.5 1.5 1.5 1.#

H /t t p50 < ,lories H +;N P &B/

Tot, C,o5i( It,e

C ,lories P mo!'t o2 i'tke (o)

G,+t5i( C,$,(it8

C "e i' mo'ths F #

G,+t5i( E%$t8i' Ti%e

C #-3 ho!rs

171 &l,t 7'2l, L,to"e' L,t!m N' Nesto"e' N!trmi'o"e' $elr"o' $rosoee

172 Bo'' N!rso $romil *-#6 *imil, *M&

THE SEVEN HABITS O HIGHL! EECTIVE PEOPLE by Stephen R. Covey

H,it H,it H,it H,it H,it

17 27 *7 >7 :7

Be P5o,(ti6e Be'i it0 t0e ed i %id P.t i5+t T0i'+ i5+t T0i 3i-3i See /i5+t to .de5+t,d ,d t0e to e .de5+tood H,it 7 S8e5'ie H,it ?7 S0,5$e t0e +,

EXPECTED LA SALLIAN GRADUATE ATTRIBUTES (!"#$ 1@ 2@

Co%$etet  +,/e $08+i(i,+ Et0i(,  +o(i,8 5e+$o+ie Do(to5+ ) $5,(titioe5+ *@ Re/e(ti6e i/eo' e,5e5+ >@ E//e(ti6e (o%%.i(,to5+ :@ E//i(iet  io6,ti6e %,,'e5+

TREATMENT PLAN A ACUTE DIARRHEA "+t le+st 3, BM in . /rs& > R.e+ o/ Ho%e T5e,t%et

DIARRHEA J J

+hro'i, C 1% ds 'o'-i'2e,tio!s ,!ses $ersiste't C 1% ds i'2e,tio!s ,!se

J

ORS 6o@ ,/te5 e,(0 oo+e +too 1 d,8 =#% mo #-10 .o. 10 .o.

5-100mL 100-#00mL &s m!,h s w'ted

500mL 1000mL #000mL

o5 +e6e5e de08d5,tio ) 3HO 08d5,tio "flui! PLR "00cc#$% & A'e =1# 1#

*;%L)' 1; 30 mi's

?:%L)' 5; #;

P,tiet i &'* J J J

#0-30,,k" I: 2st drip !t i' i'2'ts 10,,k" I: (repet i2 'ot stle) I2 respo'si4e  stle ?5k" < %-6 ho!rs

TREATMENT PLAN  ETIOLOG! o/ AGE T5e,t +e6e5e de08d5,tio UIC4L!F > B+cteri+ 1iruses 1@M,o5 Me(0,i+%+ Gi6e ext5, /.id ",+ %.(0 ,+ t0e (0id &eromo's *trt I: 2l!id immeditel &stro4ir!ses t,e& 1. i $oorl sored osmoti,ll ,ti4e s!st',es i' B,ill!s ,ere!s +lo4ir!ses l!me' +mplo,ter I2 OeO!'i the ,hild ,' dri'k "i4e Noro4ir!s R*   Brest2eed 2reE!e'tl  lo'"er t e,h 2eedi'" #. I'testi'l io' se,retio' (i',resed) or de,resed +lostridi!m per2ri'"e's  i2 the ,hild is e<,l!si4el rest2ed "i4e o'e or mo!th while the I: drip is ei'"7'teri, set !p &de'o4ir!s sorptio' +lostridi!m di22i,ile Rot4ir!s more o2 the 2ollowi'" i' dditio' restmilk 3. !tpo!ri'" i'to the l!me' o2 loodtom!,!s 7s,heri,hi ,oli +tome"lo4ir!s 8i4e 100mLk" L,tted Ri'"erQs J R* sol!tio' %. Der'"eme't o2 i'testi'l motilit $lesi omo's shi"elides ;erpes simple< 4ir!s sol!tio' J 2ood sed 2l!id (e.". so!p ri,e wter) *lmo'ell ,le' wter TREATMENT PLAN B *hi"ell i5+t 'i6e T0e 'i6e Rot,6i5, AGE (omitin% first t/en i+rr/e+) A'e *tphlo,o,,!s !re!s How much fluid to be given in addition to the usual *;%L)' i7 ?;%L)' i7 Re(o%%eded ,%o.t o/ ORS o6e5 > :irio 0o.5 $e5iod ,holere 01  013 I'"estio' fluid intake? o2 rot4ir!s  rot4ir!s i' i'testi'l 4illi I'2'ts 5 ho!rs :irio prhemolti,!s1 ho!rV destr!,tio' o2 &"e 4illi !p toC % mo = % mo 1# mo = 1#(=1#mo) mo # rs = # rs 5 rs ersi'i e'tero,oliti, Up to # ersC 50-100/tC mL 2ter e,h +hildre' =6k" 6-.k" 10-11.k" #-1k" 30 mi'V #  ho!rs (se,retor dirrhe Ssorptio' loose stool T se,retio')  &87 (1#mo-5rs) ?00-00 (mL) #00-%00 %00-?00 00-1%00 P+r+sites

1. . !.

J

J 2@

*@ >@

Bl'tidi!m ,oli # ers or moreC 1%0-#00 mL J Use ,hildQs "e o'l whe' wei"ht is 'ot k'ow' Blsto,,tis homi'is A++e++%et C- "i4e 2reE!e't o/ de08d5,tio smll sips "S$in 2rom Pinc/ ,!p Test& Re$e,t o(e i/ 5,di, $.+e i+ 6e58 e, o5 ot J &ppro or #0m" ATER HOURS ho!rs i' ,hildre' (Cotri) D < 10-1% ds J ressess the ,hild  ,lssi2 dehdrtio' stt!s Salmonella Chloramphenic ressess 2ter 6 hrs (i'2't)  3 hrs (,hild) J sele,t the pproprite pl' to ,o'ti'!eJ tretme't ol Coti.e /eedi' J e"i' 2eedi'" the ,hild while t the ,li'i, 4o 0e to 5et.5

J

7 & d 1 i 0 C d  , + t  , /  I 5 o / d e + U 8 1  o % % o C " S N O I T I S O P M O C D I U L  V I

ORS Y

G.(o8te ; -C 2or ,!te D;N se,o'dr to 87 or other 2orms o2 dirrhe e%cept CH&!R#. I' !r's post & I s!r"er repl,eme't or mi'te'',e mild-slt R Aloosi'" s'drome het ,rmps 'd het e
O L O "lucose' Cl' "luconate' R 100mmolL 50mmolL 5mmolL T N a' )g' O C 60 molL 5mmolL E *' Cit+ate' H T #0 mmolL 10 mmolL R O  Y M H8d5ite A R-C # t i' #00ml wter or 10s,hets i' 1L wter G O R "lucose' Cl' "lucose' s P r " 111mmolL A0mmolL 11mmlL L + e a' HC&,' NC O 3 5 C 0 mmolL 5mmolL 0 mmolL O t o T*' ZC 2 O mmolL #0 mmolL R#0 u P s I / R t n A o

m e % A  l i / )

ETIOLOG! O PNEUMONIA Y

Pedi,8te >: ;5 J; -C pre4e'tio' o2 D;N  to mi'ti' 'orml 2l!idele,trolte l',e i' mild to moderte dehdrtio'. "lucose %5m7E a' #0m7E *' 35m7E Cit+ate' 30m7E -e%t+ose' #0"

Y

"lucose 0m7E a' #0m7E *' A0m7E Cit+ate' 30m7E -e%t+ose' #5"

Pedi,8te %id *; -C to s!ppleme't 2l!id  ele,trolte loss d!e to ,ti4e pl prolo'"ed e
"lucose' 30m7E a' #0m7E  l *' 30m7E o s / t n o m  s t n + f n I % n u o 4

)g' %m7E lactate' #0m7E +C %m7E ne+gy' #0k,l 100ml

B,(te5i, - *trepto,o,,!s p'e!mo'ie - 8ro!p B strepto,o,,i (neonates$ - 8ro!p & strepto,o,,i - M,oplsm p'emo'ie (adolescents$ - +hlmdi tr,homtis (infants$ - Mi
(C+oup$

(bi+d bat contact$ (bi+d (immunosupp+essed$ M!,orm,osis

(immunosupp+essed H/0 ste+oids$

SMR GIRLS LUDANKS METHOD "H!DRATION THERAP!&

= 15 k" = # o  15 k" # o

MILD DEH!DRATION 50 ,,k" 30 ,,k" D5 0.3G i' 6-A ho!rs

MODERATE DEH!RATION 100 ,,k" 60 ,,k" 1st hrC [ $li' LR Ne
SEVERE DEH!DRATION 150 ,,k" 0 ,,k" 1st hrC ] $li' LR Ne
NOTE7

TOTAL LUID REUIREMENT 100 mL  k" 1000 F  50 2or e,h k" i' e<,ess o2 10 k" 1500 F  #0 2or e,h k" i' e<,ess o2 #0 k"

+omp!ted :l!e is i' mLd 7<. #5k" ,hild &'swerC 1500 F 100 H 1600,,d

AT!PICAL DENGUE PNEUMONIA  )&3' -C e
# 3 % 5

P.i( H,i5 $redoles,e't *prse li"htl pi"me'ted stri"ht medil order o2 li

B5e,+t+ $redoles,e't Brest  ppill ele4ted s smll mo!'d reol dimeter i',resed Brest  reol e'lr"ed 'o ,o'to!r seprtio' &reol  ppill 2ormed se,o'dr mo!'d Mt!re 'ipple proOe,ts reol prt o2 "e'erl rest ,o'to!r

D rke r e" i' 'i' " to ,! rl T mo !' t +o!rse ,!rl !'d't !t mo!'t = d!lt &d!lt 2emi'i'e tri'"le spred to medil s!r2,e o2 thi"h

SMR BO!S

HOLIDA!-SEGAR M ETHOD "MAINTENANCE& 3EIGHT 0 - 10 k" 11- #0 k"  #0 k"

St,'e 1

St,'e 1 2 * > :

P.i( H,i5 No'e *,'t lo'" sli"htl pi"me'ted Drker strts to ,!rl smll mo!'t Resemles d!lt tpe !t less i' E!'tit ,o!rse ,!rl &d!lt distri!tio' spred to medil s!r2,e o2 thi"h

De'.e e6e5 S8d5o%e "DS&  *-12 %o Biphsi, - R*: 2e4er (#-? ds) with # or more o2 the 22C - ther respirtor 4ir!ses 1. -hed,he *trepto,o,,!s p'e!mo'ie #. -ml"i ;emophil!s or rthrl"i i'2l!e'e (9pe B) 3. -retrooritl +. tr,homtis pi' %. -hemorrh"i, M. p'e!mo'ie m'i2esttio's -4petechiae 8ro!p & *trepto,o,,!s pu+pu+a (5$ to+ni6uet test7 5. le!kope'i  2-: 85+ - R*: De'.e He%o550,'i( e6e5 "DH& - ther respirtor 4ir!ses 1. -2e4er *trepto,o,,!s persiste'tl p'e!mo'ie hi"h "rde (#-? ds) #. -hemorrh"i, ;emophil!s m'i2esttio's i'2l!e'e (9pe B) - -+. (F)tr,homtis tor'iE!et test - -M. pete,hie p'e!mo'ie e,,hmoses p!rp!r - -8ro!p leedi'" & *trepto,o,,!s 2rom m!,!s 8I9 p!',t!re sites - -*tph mele' !re!s hemtemesis 3. 9hromo,tope'i (= 100000mm 3) %.  2-: ;emo,o',e'trtio' 85+ -- *trepto,o,,!s hemto,rit %0G p'e!mo'ie or rise o2 #0G 2rom seli'e -- ;emophil!s  drop i' #0G i'2l!e'e ;,t (2rom(9pe seli'e) B) 2ollowi'" - +. 4ol!me tr,homtis repl,eme't -- M. si"'s p'e!mo'ie o2 plsm lek"e - 8ro!p 4pleu+al&effusion *trepto,o,,!s ascites hypop+oteinemia7 - *tph !re!s

Pei+ $redoles,e't *li"htl e'lr"eme't Lo'"er

Te+te+ $redoles,e't 7'lr"ed s,rot!m pi'k te
Lr"er "l's  redth T i' sie

Lr"er s,rot!m drk

&d!lt sie

&d!lt sie

De'.e S0o( S8d5o%e M'i2esttio's o2 D; pl!s si"'s o2 ,ir,!ltor 2il!re 1. rpid  wek p!lse #. 'rrow p!lse press!re (=#0mm;") 3. hpote'sio' 2or "e %. ,old ,lmm ski'  irritilit  restless'ess

DANGER SIGNS O DH ! G 1. domi'l pi' (i'te'se  s!sti'ed) O #. persiste't 4omiti'" L O 3. r!pt ,h'"e 2rom 2e4er to hpothermi I S with sweti'" ! H %. restless'ess or som'ole',e P O H T A G5,di' o/ De'.e He%o550,'i( e6e5 P E U G N E D

MANAGEMENT O DENGUE

MANAGEMENT O HEMORRHAGE

&. :itl *i"'s 'd Lortor Mo'itori'" Mo'itor B$ $!lse Rte 8e have to watch out fo+ Shock (Hypotension)

To5i.et Te+tC *B$ F DB$ H me' B$ 2or 5 mi's. ACUTE GLOMERULONEPHRITIS # Co%$i(,tio+ i2 #0 pete,hil o/ rsh AGN per sE. i',h o' 'te,!itl 2oss -(F) +; test#> to 2l!id o4erlod - ;$N e',ephlopth -He5%,K+ &R d!e R,+07 to a 8R - !s!ll ppers 2ter 2e4er lsed - i'itill ppers o' the lower e
URINAR! RHEUMATIC TRACTEVER INECTION NE& RITERIA! &u%%estie 7TI! - $!riC /B+  5;$ or 10mm3 A@ M,o5 M,i/e+t,tio+ - &se',e - +rditiso2 p!ri does'Qt r!le o!t U9 I (50-60G) - $!ri - $olrthritis ,' e prese't wo U9I (?0G) - +hore (15-#0G) Presum2tie - 7rthem Mr"i't!m 7TI! (3G) - (-) - *!,!t'eo!s !ri'e ,!lt!re Nod!les (1G) - lower ,olo' ,o!'ts m e d!e toC B@VMio5 o4erhdrtio' M,i/e+t,tio+ V- re,e't &rthrl"i ldder empti'" V- e4er pre4io!s 'tiioti, i'tke - Lortor i'di'"s o2C Proen T &,!te or onfirme $hse Re,t'ts 7TI! (7*R  +R$) - (F) !ri'e $rolo'"ed ,!lt!re$R  100000 i'ter4l ,2!mL !ri'e o2  si'"le or"'ism C@ - m!ltiple PLUS S.$$o5ti' or"'isms i'E6ide(e ,!lt!re m o/ Ate(edet i'di,te  ,o'tmi'ted 8ro!p-& *trep smple I'2e,tio' - (F) 9hrot +!lt!re or Rpid *trep-&" 9est - TRisi'" *trep-&B 9est

TREATMENT O RHEUMATIC EVER A@ Atiioti( T0e5,$8 - 10 ds o2 rl $e'i,illi' or 7rthrom,i' - IM I'Oe,tio' o2 Be'ethi'e $e'i,illi' VVV N97C

*!mpe'

H rl $e'i,illi'b

B@ Ati-I/,%%,to58 T0e5,$8 1. &spiri' (i2 &rthritis N9 +rditis) #cuteC 100m"k"d i' % doses < 3-5ds 9he' ?5m"k"d i' % doses < % weeks #. $red'iso'e #m"k"d i' % doses < #-3weeks 9he' 5m"#%hrs e4er #-3 ds

PREVENTON A@ P5i%,58 P5e6etio - 10 ds o2 rl $e'i,illi' or 7rthrom,i' - IM I'Oe,tio' o2 Be'ethi'e $e'i,illi'

4A3ASA4I DISEASE T!PES O SEIZURES +D+-+RI97RI& R DI&8N*I*C &D$97D RM Z&/&*&ZI A@ P,5ti, Sei.5e+ "o(, ) Lo(,& (ALL SHOULD BE PRESENT) @ *imple $rtil @ +omple< $rtil (:a+tial SeiBu+e 5 A& HIGH G5,de e6e5 "*<@: Re(t,8& PRESENT /mpai+ed Consciousness$ /o5 AT LEAST :-d,8+ it0o.t ot0e5 Ex$,,tio @ $rtil *ei!res e4ol4i'" to 9o'i,-+lo'i, B@ Gee5,ied Sei.5e+ B& P5e+e(e o/ > o/ t0e : C5ite5i, 1. Bilterl +N87*9IN o2 the mal$ ,!lr +o'O!',ti4 &se',e (:etit (seen in @A) @ Mo,lo'i, #. +h'"es @ +lo'i,o2 the Lips 'd rl +4it ( #t least & ) 3. +h'"es (#t least & ) @ 9o'i, o2 the 7
@

HARADA C5ite5i, SIMPLE EBRILE SEIZURE - !sed to determi'e whether 6+@I:I" sho!ld e "i4e' - ssessed COMPLEX withi'  ds 2rom o'set o2 ill'ess EBRILE SEIZURE 1. /B+  1#000 #. $+ =350000 e5ie Sei.5e7 3. +R$i' 3F _& sei!re sso,itio' with  2erile ill'ess i' the %. ;,to2 =35G se',e  +N* i'2e,tio' or ,!te ele,trolte 5. &l!mi' =3.5 "dLolder th' 1 mo'th o2 "e iml',e i' ,hildre' 6. &"e mo'ths witho!t prior1# 2erile s ei!res` ?. 8e'derC mle Y Y

I:I" is "i4e' i2  % o2 ? re 2!l2illed I2 = % with ,o'ti'!i'" ,!te smptoms risk s,ore m!st e ressessed dil

CLASSIICATION TREATMENT B! CAUSE

SIMPLE SEIZURES EBRILE SEIZURE

A@ C.55et8 A(.te S8%$to%,ti( Re(o%%eded P5oto(o7 (sho+tly afte+ an acute insult$ I'2e,tio' A@ @IV-I%%.o'o.i @ ;po"l,emi low sodi!m low ,l,i!m @#"k" ;ed Re"ime' tr!mI'2!sio' 7cU&LL 722e,ti4e i' @$re4e'tio' 9o
A@ C5ite5i, /o5 , SS  Sei.5e+7 @ s!dde' e4e't =,!sed 15 mi'!tes  r!pt @ !',o'trolled hpers',hro'o!s 8e'erlied-to'i,-,lo'i, @ dis,hr"es o2 e4er 'e!ro's  100.% re,tl to 101  (3A to 3A.% +)  E$ie$+87 @ te'de', 2or re,!rre't No re,!rre',e sei!res i' #% tht ho!rs re @ !'pro4oked  No 'post-i,tl immedite 'e!ro ,!se 'ormlities (e.". 9oddQs presis)  St,t.+ @ e$ie$ti(.+7 30mi' Most ,ommo' or ,k-to-,k 6 mo'ths to 5 ers wo ret!r' to seli'e @ Norml de4elopme't  Etioo'87 @ No +N* i'2e,tio' or prior - : s,!lr 2erile sei!res C &:M stroke hemorrh"e - I '2e,tio's C me'i'"itis e',ephlitis -B@ 9 Ri+ r!mti, ,(to5+C - & @!toimm!'e C *L7 erile 4s,!litis sei!re i' &D7M 1st  #'d - M etoli, de"ree relti4e C ele,trolte iml',e - I @ diopthi, C _idiopthi, Neo'tl '!rser epileps` st o2 - N eoplsti, 30 ds C sp,e o,,!pi'" lesio' - * @tr!,t!rl C ,orti,l De4elopme'tl ml2ormtio' del @ prior ;ei"ht stroke o2 tempert!re - * 'drome C "e'eti, disorder C@ Ri+ ,(to5+ /o5 E$ie$+8 ( to "09 :ill %o on to /+e e2ile2s) @ De4elopme'tl del @ +omple< * (possil  1 ,omple< 2et!re) @ 5G  30 mi's H  o2 ll ,hildhood stt!s @ mil ;istor o2 7pileps @ D!rtio' o2 2e4er

C@ ;I8; Idio$,t0i( Dose &*& (A0-100m"k"d di4ided E 6h) @ sho!ld No histor e "i4e' o2I'itill pre,edi'" i' +o'O!',tio' i's!lt with I:-I8 @ Likel _"e'eti,` ,ompo'e't 9;7N Red!,ed to Low Dose &spiri' (3-5m"k"d) &ND +o'ti'!ed !'til +rdi, 74l!tio' +M$L797D (app+o%imately 1;2 months #3R &nset of -isease)

BRONCHIAL ASTHMA (;INA ;7I
D smptoms Limittio' o2 ,ti4ities No,t!r'l *< (wke'i'") Need 2or relie4er L!'" 2!',tio' 7<,ertio'

Cot5oed

P,5t8 Cot5oed

'o'e

 #< per wk

'o'e

'

'o'e

'

= #< per wk

 #< per wk

'orml

= A0G

'o'e

 1< per r

U(ot5oed

3 or more smptoms o2 $rtl +o'trolled &sthm i' ' week

1<  week

Cii(, e,t.5e+7 TUBERCULOSIS

RESPIRATOR! DISTRESS S!NDROME "H8,ie Me%5,e Di+e,+e&

A@ P.%o,58 TB @ 2!ll s!s,eptile M. t!er,!losis @ 'o histor o2 pre4io!s 'ti-9B dr!"s @ low lo,l persiste',e o2 primr resist',e to Iso'iid (;)

o

o

#;R D

☤

the' %;R D or 3<wk D9 @ Mi,roil s!s,eptiilit !'k'ow' or i'itil dr!" resist',e s!spe,ted (e.". ,4itr) @ pre4io!s 'ti-9B !se @ ,lose ,o't,t w resist't so!r,e ,se or li4i'" i' hi"h res w hi"h p!lmo'r resist',e to ;. @

☤

#;R F 7* D the' % ;R F 7* D or 3<week D9

o

Ext5,$.%o,58 TB @ *me i' $9B @ or se4ere li2e threte'i'" disese (e.". milir me'i'"itis o'e et,) ☤

#;R F 7* D the' 10;R F 7* D or 3<wk D9

+orti,osteroidsC Y most s!,,ess2!l method to i'd!,e 2etl l!'" mt!rtio' Y &dmi'istered #%-%A ho!rs e2ore deli4er de,rese i',ide',e o2 RD* Y Most e22e,ti4e e2ore 3% weeks &8 Mi,ros,opi,llC di22!se tele,tsis eosi'ophili, memr'e

P,t0o$08+ioo'87 1.

Impir eddeled s!r2,t't s't hesis  se,retio'

#. B@

Mle preterm low B/ mter'l DM  peri'tl sph
3. %. 5. 6.

:c (4e'tiltio'per2!sio') iml',e d!e to de2i,ie', o2 s!r2,t't 'd de,resed l!'" ,ompli',e ;po
". A.

$rotei'o!s e
1. 9,hp'e 'sl 2lri'" s!,ostl 'd i'ter,ostl retr,tio's ,'osis "r!'ti'" #. $llor @ 2rom 'emi peripherl 4so,o'stri,tio' 3. 'set @ withi' 6 ho!rs o2 li2e $ek se4erit @ #-3 ds Re,o4er @ ?# ho!rs Ret5,(tio+7 D!e to (-) i'trple!rl press!re prod!,ed  o i'ter,tio' w ,o'tr,tio' o2 diphr"m  other respirtor m!s,les 'd me,h'i,l properties o2 the l!'"s  ,hest wll N,+, /,5i'7 D!e to ,o'tr,tio' o2 le 'si m!s,les ledi'" to o mrked red!,tio' i' 'sl resist',e G5.ti'7 7
@ to'"!e  m'!,os (imp. I'di,tor o2 impired "s e<,h'"e)X depe'ds o' totl mo!'t o2 dest!rted ;"

UMBILICAL CATHERIZATION NE3BORN RESUSCITATION 

AIR3A!7 ope'  ,ler $ositio'i'" • *!,tio'i'" • •

7'dotr,hel i't!tio' (if necessa+y$

C,t0et0e5 e't0 *t'drdie 8rph $erpedi,!lr li'e 2rom the tip o2 the sho!lder to the !mili,!s Mes!re le'"th 2rom Piphoid to !mili,!s 'd dd 0.5 to 1,m. Birth wei"ht re"ressio' 2orm!l Low li'e C U& ,theter i' ,m H B/ F ? ;i"h li'e C U& ,theter H 3
Idi(,tio+ :s,!lr ,,ess (U:) Blood $ress!re (U&) 'd lood "s mo'itori'" i' ,riti,ll ill i'2'ts

•

•

–

•

•

Co%$i(,tio+ I'2e,tio' Bleedi'" ;emorrh"e $er2ortio' o2 4essel 9hromosis w distl emolitio' Is,hemi or i'2r,tio' o2 lower e
•

•



–

•

BREATHING is spo't'eo!s or ssisted

–

•

–

•



•

9,tile stim!ltio' (d+ying +ubbing$

•

$ositi4e-press!re 4e'tiltio'

CIRCULATION o2 o<"e'ted lood is deE!te +hest ,ompressio's • Medi,tio' 'd 4ol!me e
P5o(ed.5e Determi'e the le'"th o2 the ,theter Restri' i'2't 'd prep the re !si'" sterile te,h'iE!e l!sh ,theter with sterile sli'e sol!tio' $l,e !mili,l tpe ro!'d the ,ord. +!t ,ord o!t 1.5-#,m 2rom the ski'. Ide'ti2 the lood 4essels. (1thinvein 2thicka+te+y$ 8rsp the ,theter 1,m 2rom the tip. I'sert i'to the 4ei' imi'" towrd the 2eet. *e,!re the ,theter ser4e 2or possile ,ompli,tio's

• •

• •

• •

• •

C,.tio+ Ne4er 2orC mphlitis $erito'itis +o'tri'di,ted i' N7+ I'testi'l hpoper2!sio' •

•

– –

RESUSCITAION MEDICATIONS

•

•

–

&tropi'e Bi,ro'te +l,i!m +l,i!m ,hloride + l, i! m "l !, o' t e De
0.0# mlk IM I: 79 1-# meEk 10 m" elem +k slow I: 0.33k (#? m" + ,,) 1 , , k ( m" +  ,, ) 1"k H # ,,k D50 % ,,k D#5 0.01 ,,k I: 79

• •

–

Lie P,(e%et &rteril li'e Low li'e 9ip lie o4e the i2!r,tio' etwee' L3  L5 ;i"h li'e 9ip is o4e the diphrm etwee' 96  9 • •

–

•

–

BILIRUBIN PRETERM7 0-1 hr 1-# d 3-5 d

%')d 1-6 6-A 10-1#

%%o)L 1?-100 100-1%0 1?0-#00

%')d #-6 6-? %-1# =1

%%o)L 3%-100 100-1#0 ?0-#00 =1?

TERM 0-1 hr 1-# d 3-5 d 1 mo

4RAMERS CLASSIICATION O AUNDICE ZONE

AUNDICE

I

;ed  'e,k Upper tr!'k to !mili,!s Lower tr!'k to thi"h &rms le"s elow ;'ds  2eet

II III I: :

SERUM BILIRUBIN 6-A -1# 1#-16 15 15

76425539-Pedia-tickler.doc

Recommend Documents